Trial intelligence / Profile preview

DEBAT trial of bromocriptine effects on brown adipose tissue

NL-OMON38797Active, not recruiting

Sponsor
Amsterdam University Medical Center
Start
Oct 2013
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of bromocriptine and domperidone in obesity and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Amsterdam University Medical Center. Started Oct 2013; status: active, not recruiting.

02

Drugs

bromocriptinedomperidone
03

Conditions

obesitytype 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NL-OMON38797.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON38797.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call